Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.

Schilsky, Richard L; Levin, Jeremey; West, William H; Wong, Alfred; Colwell, Bruce; Thirlwell, Michael P; Ansari, Rafat H; Bell, William N; White, Robin L; Yates, Barbara B; McGuirt, Paul V; Pazdur, Richard

Schilsky, Richard L; Levin, Jeremey; West, William H; Wong, Alfred; Colwell, Bruce; Thirlwell, Michael P; Ansari, Rafat H; Bell, William N; White, Robin L; Yates, Barbara B; McGuirt, Paul V; Pazdur, Richard.

Affiliation

Schilsky RL; Biological Sciences Division, University of Chicago, Chicago, IL 60637-1463, USA.

J Clin Oncol ; 20(6): 1519-26, 2002 Mar 15.

Article in En | MEDLINE | ID: mdl-11896100

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uracil / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2002 Document type: Article Affiliation country:

Search on Google

Add to My VHL

XML

PubMed Links